Aggregate Spending & Regulatory Compliance Solutions for Pharmaceutical, Healthcare, Life Sciences, Biomedical, Medical Device Manufacturers - Porzio Life Sciences
HomeProducts & ServicesAbout UsContact UsSubscriber LoginGoToMeetingBlog
  • /Images-(1)/homepage-rotator/Intro-Slide.aspx
  • /Images-(1)/homepage-rotator/Porzio-Compliance-Digest.aspx
  • /Images-(1)/homepage-rotator/Porzio-Aggregate-Spend.aspx
  • /Images-(1)/homepage-rotator/Porzio-Licensing-Services.aspx
  • /Images-(1)/homepage-rotator/Porzio-Compliance-Modules.aspx
  • /Images-(1)/homepage-rotator/Significant-Loss-Assurance.aspx
 

Aggregate Spend Solutions and Regulatory Compliance Products

Porzio Life Sciences’ regulatory compliance software solutions, products and services assist pharmaceutical, medical device and biotechnology companies in complying with marketing and sales regulations, including PDMA, anti-kickback statutes, False Claims Act, FDA, OIG, Physician Payments Sunshine Act and state aggregate spend compliance regulations.

Porzio AggregateSpendID is an automated web-based solution for spend and samples data capture, tracking and reporting.  The system collects spend associated with sales representatives, senior executives, medical meetings, clinical trials, grants, eGrants, speaking fees, honoraria, etc.
 

Products and Services

Porzio AggregateSpendID— Web-based system to track spend and samples directed towards healthcare providers and organizations - read more 


Porzio Compliance Digest
— Searchable databases of sales and marketing statutes, regulations and pending legislation - read more 


Licensing Services— Identify, acquire and amend required state distribution licenses for drug and device manufacturers and distributors - read more 


Significant Loss Threshold Assurance
—Formula-based sample accountability - read more  
 

Porzio Compliance Modules— "At-a-glance" information, regulations and agency rules - read more 

News

Sarah Canberg Quoted in Compliance Week Article on the Continued Sunshine Act Struggle for Healthcare Companies 
Sarah M. Canberg, Associate of Porzio, Bromberg & Newman and Manager of Regulatory and Compliance Services of Porzio Life Sciences, LLC is quoted in the Compliance Week article "Healthcare Companies Struggling Still With Sunshine Act Compliance.” - read more


Careers  Porzio Life Sciences seeks a full-time COMPLIANCE SERVICES ASSISTANT and full-time, entry-level REGULATORY ASSISTANT for our Morristown office - read more

AdvaMed is the world’s largest medical technology association representing manufacturers of medical devices, diagnostics products, and medical information systems - read more


Christine Bradshaw and Sarah Canberg Quoted in Article on the Sunshine Act’s Complexity 
Christine N. Bradshaw, Associate of Porzio, Bromberg & Newman and Director of Regulatory and Compliance Services of Porzio Life Sciences, LLC and Sarah M. Canberg, Associate of Porzio, Bromberg & Newman and Manager of Regulatory and Compliance Services of Porzio Life Sciences, LLC are quoted in the Compliance Week article "Final Version Provides Little Relief for Complex Sunshine Act.” - read more or go to Compliance Week


Scott Liebman and Christine Bradshaw Quoted in Article on the Finalization of the Sunshine Act 
Scott Liebman, Principal of Porzio, Bromberg & Newman and Vice President of Porzio Life Sciences and Christine Bradshaw, Associate of Porzio, Bromberg & Newman and Director of Regulatory and Compliance Services of Porzio Life Sciences are quoted in the article "The Sunshine Act is Finally Final" in the Pharma & Healthcare section of Forbes.com - read more  or go to Forbes


Scott S. Liebman Quoted In Article on DOJ Manufacturing Regulations
 

Scott Liebman, Principal and Vice President of Porzio Life Sciences is quoted in the article "In Notable Shift, DOJ to Treat Manufacturing Regulations as 'Top Area of Focus' in 2013" in a Regulatory Affairs Professionals Society (RAPS) Regulatory Focus article - read more


Michelle Axelrod and Ed Crowe Present at MassDevice Big 100 Roundtable West
 
Michelle Axelrod and Ed Crowe joined representatives from KHJ Brand Activation and Greenberg Traurig to kick off The MassDevice Big 100 Roundtable with a special session called "Sparking the Conversation: Hot Topics.” - read more


Elizabeth Kim & Kiaema Reid, Co-Authors of Compliance Manual
Porzio Life Sciences’s Elizabeth H. Kim, Manager of Regulatory and Compliance Services and Kiaema Reid, Senior Regulatory Analyst, are contributors to the composition of the “Pharmaceutical and Medical Device Compliance Manual,” - read more


Frank Fazio Quoted in Article on Medical Device Licensing Required by States
 
Frank Fazio, Principal of Porzio, Bromberg & Newman and Vice President of Distribution and Licensing Services of Porzio Life Sciences is quoted in the article "Licensed to Sell" in the IMDA (Independent Medical Distributors Association) e-newsletter - read more


Scott Liebman Named Leader of Bar By NJ Law Journal 
Porzio Life Sciences is pleased to announce that our Vice President, Scott Liebman, has been named a Leader of the Bar by New Jersey Law Journal - read more


Supreme Court Upholds Affordable Care Act
United States Supreme Court upheld the Patient Protection and Affordable Care Act (“ACA”) in its entirety - read more



More News

Events

Ed Crowe to attend the American Diabetes Association 73rd Scientific Sessions 
This year's Scientific Sessions introduces new program features and advancements that will make the meeting one of the most interesting and interactive conferences on diabetes to date on June 21-25, 2013 - read more


Hot Topics in Healthcare Compliance:
What are Your Major Risk Areas?
 
Medical device companies face many healthcare compliance risks in their drive to develop and commercialize new technologies and grow their businesses. Two of the most critical areas are interactions with healthcare professionals (HCPs) and off-label product communications - MassMEDIC in Waltham, MA on June 13, 2013 - read more

The Manufacturers Forum, which is held in conjunction with the Conference, is a meeting place for specialty sales and marketing organizations and manufacturers of new medical technologies who are seeking specialty representation on June 9-11, 2013 - read more
 
 
CBI's ABAC 2013 – Global Third Party Diligence, Audit and Oversight in Washington, DC.  Over the past few years, regulators around the globe have been increasing their resources and efforts investigating potential bribery and corruption on June 5-6, 2013 - read more
 
 
The device and diagnostics industry is in the spotlight of regulators and enforcement agencies to ensure that interactions with HCPs in the U.S. and abroad are compliant on June 4-5, 2013 - read more


John Oroho to speak at and Jeffrey Campbell, Brian Sharkey and Christine Bradshaw to attend the 7th International Pharmaceutical Compliance Congress and Best Practices Forum in Madrid, Spain

John Oroho to speak at and Jeffrey Campbell, Brian Sharkey and Christine Bradshaw to attend the 7th International Pharmaceutical Compliance Congress and Best Practices Forum from May 21-23, 2013 in Madrid, Spain - read more

John Oroho, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, attended the Concur Fusion 2013 Conference in Las Vegas, NV from April 16-19, 2013 - read more
 
 
Scott Liebman, Vice President of Porzio Life Sciences, attended the TEDMED 2013 Conference in Washington, DC from April 16-19, 2013 - read more
 
 
CBI’s 4th Annual West Coast Forum on Sunshine and Aggregate Spend in San Diego, CA, from April 23-25, 2013 - read more


Ed Crowe Attended the MDMA 2013 Annual Meeting 

Ed Crowe, a PorzioLS Director, to attend the MDMA 2013 Annual Meeting in Washington, DC from April 15-17, 2013 - read more 


Jeffrey Campbell, John Oroho and Brian Sharkey Attended CBI’s 3rd Global Transparency Reporting Congress 
Jeffrey Campbell, John Oroho and Brian Sharkey attended CBI’s 3rd Global Transparency Reporting Congress in Brussels. As practices for spend on healthcare providers (HCPs) have come under increased scrutiny, “transparency” has become a buzzword with growing weight - read more


Sarah Canberg Attended CBI’s Compliance Monitoring Programs 

Sarah Canberg, PorzioLS's Manager of Regulatory and Compliance Services, attended the CBI Compliance Monitoring Programs in Philadelphia, PA from March 19-20, 2013 - read more

The Sunshine Act
Lawline CLE Webinar 
On Wednesday, March 13, 2013 at 2:00 pm, Christine N. Bradshaw, J.D. Director of Regulatory and Compliance Services and Sarah M. Canberg, J.D. Manager of Regulatory and Compliance Services had a thorough discussion of the Sunshine Act, including the final rule recently promulgated and the proposed report templates released by the Centers for Medicare and Medicaid Services (CMS) - read more or watch webinar now.  


More Events

 
 

Articles

Trend Towards Global Transparency
The Trend Towards Global Transparency:
A Challenging New World for the Life Sciences Industry - read more


Pharma Sales Reps Exempt from Overtime
U.S. Supreme Court declares pharmaceutical sales
representatives exempt from overtime under the Fair Labor Standards Act
- read more


Understanding Sunshine Act
Understandng the Sunshine Act: Dispersing The Clouds of Confusion. On March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act.  Section 6002 of the Act, entitled “Transparency Reports and Reporting of Physician Ownership or Investment Interests,” is commonly known as the “Sunshine Act.” - read more


Life Sciences 2012: Getting the Deal Through 
Life Sciences in 25 jurisdictions worldwide - The health-care system in the United States has evolved over the past 60 years through incremental public policy initiatives. These public policy changes have mainly been on the federal level - read more


More Articles